grxD Antibody

What is grxD and why is it important in research?

grxD (Glutaredoxin 4) is a monothiol glutaredoxin characterized by a conserved CGFS active site motif. It plays crucial roles in iron-sulfur (Fe-S) cluster biogenesis and iron homeostasis across prokaryotes and eukaryotes. Unlike classical dithiol glutaredoxins with CXXC motifs, monothiol glutaredoxins like grxD don't primarily function in redox chemistry but are essential for:

• Coordinating and transferring iron-sulfur clusters to target proteins

• Regulating cellular responses to iron availability

• Protecting cells against oxidative stress

• Contributing to virulence in pathogenic bacteria

Research on grxD is particularly significant as it reveals mechanisms of iron metabolism, a fundamental process across all biological systems .

What are the structural characteristics of grxD that antibodies typically target?

grxD antibodies typically target epitopes within the 115-amino acid sequence of the protein. Key structural characteristics include:

• A conserved active site cysteine (Cys-30 in E. coli) within the CGFS motif essential for iron-sulfur cluster coordination

• A dimeric interface where the iron-sulfur cluster bridges two protomers

• Coordination sites where each protomer contributes the active site cysteine and non-covalently bound glutathione

In some organisms, grxD contains distinct domains:

• A thioredoxin (Trx)-like domain at the N-terminus

• A glutaredoxin (Grx) domain containing the CGFS motif

These structural elements are crucial considerations when selecting antibodies for specific experimental applications .

How do grxD homologs differ across species?

grxD homologs share functional conservation but exhibit important species-specific differences:

When using antibodies, these differences must be considered as epitopes may vary, affecting cross-reactivity and experimental design .

What criteria should researchers use when selecting a grxD antibody for specific applications?

When selecting a grxD antibody, researchers should consider:

• Target specificity: Verify the antibody recognizes your species of interest. For instance, antibodies raised against E. coli grxD may not cross-react with eukaryotic homologs due to sequence divergence.

• Application compatibility: Confirm validation for your intended application:

  • Western blotting (WB): Most grxD antibodies are validated for WB at dilutions between 1:1000-1:5000

  • ELISA: Usually requires different optimization than WB

  • Immunofluorescence: May require specific fixation protocols

• Epitope location: Consider whether your experiment requires:

  • Antibodies recognizing the active site (CGFS motif)

  • Antibodies targeting unique domains (e.g., Trx domain in fungal GrxD)

  • Antibodies to full-length protein vs. specific regions

• Clonality:

  • Polyclonal antibodies offer broader epitope recognition

  • Monoclonal antibodies provide greater consistency between lots

• Host species: Consider compatibility with other antibodies in multi-labeling experiments to avoid cross-reactivity .

How should researchers validate a grxD antibody before experimental use?

Comprehensive validation of grxD antibodies should include:

• Specificity testing:

  • Use knockout/deletion mutants (e.g., ΔgrxD) as negative controls

  • Test for cross-reactivity with closely related glutaredoxins

  • Perform peptide competition assays with immunizing antigen

• Application-specific validation:

  • For Western blotting: Verify band size matches predicted molecular weight (~17 kDa for grxD, though apparent MW may vary with tags or post-translational modifications)

  • For immunofluorescence: Compare localization patterns with known cellular distribution (e.g., mitochondrial for GLRX5)

• Dilution optimization:

  • Test multiple dilutions around manufacturer recommendations (typically 1:1000-1:5000 for WB)

  • Optimize secondary antibody concentrations to minimize background

• Positive controls:

  • Use recombinant grxD protein as positive control

  • Include wild-type samples alongside mutants

• Expression system considerations:

  • For studies in E. coli, co-expression with pRKISC significantly increases detection levels of grxD protein .

What differences should be considered when using antibodies against different glutaredoxin family members?

When working with antibodies against different glutaredoxin family members, researchers should consider:

• Sequence homology challenges:

  • Monothiol (CGFS) vs. dithiol (CXXC) glutaredoxins have distinct evolutionary origins

  • Within monothiol glutaredoxins, sequence conservation can lead to cross-reactivity

• Domain architecture differences:

  • Single-domain glutaredoxins (e.g., E. coli grxD) vs. multi-domain proteins (e.g., human GLRX3)

  • Presence of thioredoxin domains in some family members

• Subcellular localization:

  • Mitochondrial (GLRX5) vs. cytosolic (GLRX3) localization affects sample preparation

  • Different extraction buffers may be needed for optimal results

• Post-translational modifications:

  • Fe-S cluster binding alters protein conformation and may affect epitope accessibility

  • Glutathionylation states can impact antibody recognition

• Comparative analysis approach:

  • When studying multiple glutaredoxins, use a panel of well-characterized antibodies

  • For unknown cross-reactivity, pre-adsorption with recombinant proteins can improve specificity .

What are the optimal conditions for using grxD antibodies in Western blotting?

For optimal Western blotting with grxD antibodies, follow these methodological recommendations:

• Sample preparation:

  • For bacterial samples: Use sonication in PBS with protease inhibitors

  • For eukaryotic cells: Include reducing agents (DTT or β-mercaptoethanol) to preserve protein state

  • Normalize protein loading to 20-50 μg total protein per lane

• Gel selection and transfer:

  • Use 12-15% polyacrylamide gels due to the small size of grxD (~17 kDa)

  • Transfer to PVDF membranes at 100V for 1 hour or 30V overnight for optimal protein retention

• Blocking conditions:

  • 5% non-fat dry milk in TBST for 1 hour at room temperature

  • For phospho-specific applications, 5% BSA may reduce background

• Antibody incubation:

  • Primary: 1:1000-1:5000 dilution in blocking buffer, overnight at 4°C

  • Secondary: 1:5000-1:10000 HRP-conjugated antibody for 1 hour at room temperature

• Detection optimization:

  • Use enhanced chemiluminescence (ECL) with exposure times of 30 seconds to 5 minutes

  • For weak signals, consider enhanced ECL substrates or signal amplification systems

• Controls and validation:

  • Include recombinant grxD as positive control

  • For bacterial systems, compare wild-type and ΔgrxD mutant strains

  • When validating new antibodies, perform peptide competition assays .

How can researchers effectively use grxD antibodies for immunofluorescence and localization studies?

For effective immunofluorescence and localization studies using grxD antibodies:

• Cell fixation and permeabilization:

  • For eukaryotic cells: 4% paraformaldehyde (PFA) fixation for 15 minutes followed by 0.1% Triton X-100 permeabilization

  • For bacteria: 4% PFA for 20 minutes, followed by lysozyme treatment to enhance antibody penetration

• Blocking optimization:

  • 5% normal serum (from the species of secondary antibody) for 30-60 minutes

  • Include 0.1% BSA to reduce non-specific binding

• Antibody incubation parameters:

  • Primary: 1:100-1:500 dilution, overnight at 4°C

  • Secondary: 1:500-1:1000 fluorophore-conjugated antibody, 1 hour at room temperature

  • Include nuclear counterstain (DAPI) in the final wash steps

• Co-localization techniques:

  • For mitochondrial localization (GLRX5): Co-stain with MitoTracker or antibodies against mitochondrial markers

  • For iron-sulfur cluster research: Combine with markers for ISC assembly machinery

• Confocal imaging parameters:

  • Use sequential scanning to prevent bleed-through with multiple fluorophores

  • Employ Z-stack acquisition for 3D localization analysis

• Quantification approaches:

  • Measure co-localization coefficients (Pearson's, Mander's) for organelle association

  • Analyze fluorescence intensity under different experimental conditions (e.g., iron starvation vs. sufficiency) .

What strategies are effective for using grxD antibodies to study protein-protein interactions?

For studying protein-protein interactions involving grxD using antibodies:

• Co-immunoprecipitation (Co-IP) protocols:

  • Cell lysis: Use gentle, non-denaturing buffers (e.g., 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40) to preserve protein complexes

  • Pre-clearing: Incubate lysates with protein A/G beads to reduce non-specific binding

  • Immunoprecipitation: Use 2-5 μg antibody per 500 μg protein lysate

  • Analysis: Western blot with antibodies against predicted interaction partners

• Proximity ligation assay (PLA):

  • Particularly useful for detecting transient interactions

  • Requires antibodies from different host species

  • Can visualize interactions with BolA proteins or components of iron-sulfur cluster machinery

• Chromatin immunoprecipitation (ChIP):

  • For studying interactions of grxD with DNA-binding proteins like transcription factors

  • Requires crosslinking with formaldehyde before immunoprecipitation

  • Can reveal regulatory roles in iron-responsive gene expression

• Pull-down validation approaches:

  • Confirm Co-IP results with reverse pull-downs

  • Use tagged recombinant proteins as controls

  • Perform reciprocal Co-IPs to verify specific interactions

• Interaction network analysis:

  • Combine with mass spectrometry for unbiased interactome mapping

  • Use specific buffers to preserve iron-sulfur cluster-dependent interactions

  • Consider iron availability conditions that may affect interaction dynamics .

How can grxD antibodies be used to investigate iron-sulfur cluster transfer mechanisms?

To investigate iron-sulfur cluster transfer mechanisms using grxD antibodies:

• In vitro transfer assay setup:

  • Express and purify recombinant grxD with intact Fe-S clusters

  • Use apo-ferredoxin (Fdx) as a model acceptor protein

  • Monitor transfer spectroscopically by UV-visible absorption changes

  • Confirm results with antibody-based detection of Fe-S cluster occupancy

• Immunoprecipitation-coupled spectroscopy:

  • Immunoprecipitate grxD complexes under anaerobic conditions

  • Analyze Fe-S cluster integrity by UV-visible spectroscopy of immunoprecipitates

  • Compare homodimeric and heterodimeric (with BolA) forms of grxD

• Antibody-mediated inhibition studies:

  • Test whether specific antibodies block Fe-S cluster coordination sites

  • Use as a tool to dissect transfer mechanisms

  • Compare with site-directed mutagenesis of critical residues (e.g., Cys30)

• Quantitative analysis of transfer efficiency:

  • Develop ELISA-based methods to quantify iron-sulfur cluster occupancy

  • Use antibodies recognizing conformational changes associated with cluster binding

  • Apply to compare wild-type vs. mutant proteins

• Visualization of transfer events:

  • Employ proximity-based fluorescence techniques with antibody conjugates

  • Monitor real-time transfer events in reconstituted systems

  • Correlate with functional outcomes in cellular models .

How can researchers use grxD antibodies to study the relationship between oxidative stress and iron-sulfur cluster biogenesis?

To study the relationship between oxidative stress and iron-sulfur cluster biogenesis using grxD antibodies:

• Stress-response protocol design:

  • Expose cells to oxidative stressors (H₂O₂, paraquat, tert-butyl hydroperoxide)

  • Analyze changes in grxD expression and post-translational modifications

  • Use different concentrations and time points to establish dose-response relationships

• Quantitative techniques:

  • Develop quantitative Western blotting to measure absolute grxD levels

  • Pair with qPCR to correlate protein and transcript abundance

  • Establish standard curves using recombinant proteins

• Modification-specific antibody applications:

  • Use redox-sensitive dyes or antibodies to detect thiol modifications

  • Employ non-reducing gels to preserve disulfide bonds

  • Compare with mass spectrometry to identify specific modifications

• Functional correlation studies:

  • Combine with activity assays for iron-sulfur enzymes (e.g., aconitase)

  • Correlate enzyme activity with grxD expression/modification levels

  • Use mathematical modeling to establish cause-effect relationships

• Compartment-specific analysis:

  • For eukaryotic systems, isolate mitochondria to study organelle-specific responses

  • Use subcellular fractionation with marker validation

  • Analyze grxD redistribution during stress responses .

How can grxD antibodies be employed in studying pathogen virulence mechanisms?

For studying pathogen virulence mechanisms using grxD antibodies:

• Infection model experimental design:

  • Compare wild-type and ΔgrxD mutant pathogen strains in infection models

  • Use antibodies to monitor grxD expression during different infection stages

  • Correlate with virulence factor production and host response markers

• Host-pathogen interaction analysis:

  • Immunofluorescence to visualize grxD during host cell invasion

  • Co-stain for host defense components (e.g., NADPH oxidase)

  • Analyze temporal regulation during infection progression

• Antibiotic resistance mechanism studies:

  • Monitor grxD expression in response to antibiotic treatment

  • Compare with other stress response markers

  • Develop high-throughput screening assays for compounds affecting grxD function

• Biofilm formation analysis:

  • Use antibodies to detect grxD in biofilm matrix

  • Correlate with extracellular polysaccharide production

  • Compare planktonic vs. biofilm expression patterns

• Translational research applications:

  • Develop diagnostic tests based on grxD detection

  • Screen for inhibitors of grxD as potential antimicrobials

  • Use in pharmacodynamic studies of novel therapeutic agents .

What are common challenges when working with grxD antibodies and how can they be addressed?

Common challenges when working with grxD antibodies and their solutions include:

• Non-specific binding and high background:

  • Problem: Multiple bands in Western blots or diffuse staining in immunofluorescence

  • Solutions:

    • Increase blocking time/concentration (5-10% milk or BSA)

    • Use alternative blocking agents (casein, fish gelatin)

    • Pre-adsorb antibody with lysates from knockout organisms

    • Optimize antibody dilution with titration experiments

• Weak or absent signal:

  • Problem: No detectable bands despite confirmed protein expression

  • Solutions:

    • For bacterial studies, co-express with pRKISC to increase Fe-S protein levels

    • Try alternative extraction methods to preserve protein structure

    • Use signal enhancement systems (amplified chemiluminescence)

    • Try multiple antibodies targeting different epitopes

• Inconsistent results between experiments:

  • Problem: Variable band intensity or localization patterns

  • Solutions:

    • Standardize culture conditions, especially iron availability

    • Prepare fresh stocks of reducing agents

    • Implement strict temperature control during all steps

    • Use internal loading controls appropriate for your experimental conditions

• Cross-reactivity with related proteins:

  • Problem: Unable to distinguish between glutaredoxin family members

  • Solutions:

    • Use knockout controls to confirm specificity

    • Perform immunoprecipitation followed by mass spectrometry

    • Pre-adsorb antibody with recombinant related proteins

    • Consider generating epitope-specific antibodies .

How should researchers interpret changes in grxD protein levels under different experimental conditions?

For interpreting changes in grxD protein levels under different experimental conditions:

• Iron availability effects:

  • In most organisms, grxD protein levels increase under iron limitation

  • Verify with independent methods (qPCR, reporter assays)

  • Consider post-translational regulation separate from transcriptional control

  • Compare with other iron-regulated proteins to establish patterns

• Oxidative stress responses:

  • Acute vs. chronic stress may produce different patterns

  • Analyze both total protein levels and subcellular distribution

  • Consider modifications that might affect antibody recognition

  • Correlate with functional changes in iron-sulfur enzyme activities

• Growth phase considerations:

  • Normalize to appropriate loading controls for each growth phase

  • Consider that reference "housekeeping" proteins may also change

  • Use multiple normalization strategies when possible

  • Present both absolute and relative quantification when available

• Statistical analysis recommendations:

  • Perform at least three biological replicates

  • Use appropriate statistical tests for your experimental design

  • Report effect sizes alongside p-values

  • Consider using ANOVA for multi-condition comparisons rather than multiple t-tests

• Integrative data interpretation:

  • Combine protein level data with enzyme activity measurements

  • Consider the entire iron-sulfur cluster biogenesis pathway

  • Develop models that account for feedback mechanisms

  • Validate with genetic approaches (knockdown, overexpression) .

How can researchers distinguish between direct and indirect effects when studying grxD function using antibodies?

To distinguish between direct and indirect effects when studying grxD function:

• Experimental design strategies:

  • Use inducible expression systems with time-course analysis

  • Employ domain-specific antibodies to dissect functional contributions

  • Compare point mutants affecting specific functions (e.g., C29S mutants)

  • Develop rapid induction systems to capture immediate responses

• Causal relationship establishment:

  • Combine with biochemical reconstitution using purified components

  • Use structure-function analysis with targeted mutations

  • Perform rescue experiments with wild-type vs. mutant proteins

  • Apply small molecule inhibitors with known mechanism of action

• Network analysis approaches:

  • Use systems biology tools to map regulatory networks

  • Compare immediate vs. delayed responses

  • Apply mathematical modeling to predict direct targets

  • Validate key predictions with targeted experiments

• Protein-protein interaction verification:

  • Confirm interactions using multiple methods (Co-IP, PLA, FRET)

  • Map interaction domains with truncated proteins

  • Test interaction dependency on specific conditions (redox state, iron availability)

  • Use crosslinking approaches to capture transient interactions

• Controls for antibody-based studies:

  • Include isotype controls for all immunoprecipitation experiments

  • Perform parallel experiments with non-specific antibodies

  • Validate key findings with alternative methods

  • Consider epitope masking that might occur in certain protein complexes .

How are grxD antibodies being used in studying human disease models related to iron metabolism disorders?

grxD antibodies are increasingly applied in human disease models related to iron metabolism disorders:

• Anemia research applications:

  • Study GLRX5 (human homolog) in sideroblastic anemia models

  • Monitor protein levels in patient samples vs. controls

  • Analyze correlation between GLRX5 deficiency and clinical parameters

  • Test potential therapeutic approaches targeting this pathway

• Neurodegenerative disease connections:

  • Investigate altered glutaredoxin function in Friedreich's ataxia and Parkinson's disease

  • Use antibodies to track iron-sulfur protein dysfunction

  • Study mitochondrial GLRX5 in neuronal models

  • Correlate with markers of oxidative damage

• Cancer biology applications:

  • Examine GLRX3 levels in various cancer types

  • Study relationship between glutaredoxins and tumor cell metabolism

  • Investigate connections to cancer cell responses to oxidative stress

  • Develop prognostic markers based on glutaredoxin expression patterns

• Methodological advances:

  • Multiplex immunohistochemistry in patient tissue samples

  • Development of conformation-specific antibodies for disease states

  • Circulating biomarker detection in minimally invasive samples

  • Companion diagnostics for targeted therapies

• Therapeutic development:

  • Screen for compounds affecting glutaredoxin function

  • Monitor treatment responses using antibody-based assays

  • Develop antibody-based targeted delivery of therapeutics

  • Use in pharmacodynamic and pharmacokinetic studies .

What new techniques are being developed to study grxD protein dynamics using antibody-based approaches?

Emerging techniques for studying grxD protein dynamics with antibody-based approaches include:

• Advanced imaging methodologies:

  • Super-resolution microscopy (STORM, PALM) to visualize grxD distribution at nanoscale resolution

  • Single-molecule tracking with antibody fragments to monitor real-time dynamics

  • Expansion microscopy for improved spatial resolution of protein complexes

  • Correlative light and electron microscopy to link function with ultrastructure

• Biosensor development:

  • FRET-based sensors using antibody fragments to detect conformational changes

  • Split-protein complementation assays for monitoring protein-protein interactions

  • Nanobody-based sensors for live-cell imaging of grxD dynamics

  • Intracellular antibody-based reporters for iron-sulfur cluster occupancy

• Proteomics integration:

  • Antibody-mediated proximity labeling (BioID, APEX) to map dynamic interactomes

  • Targeted proteomics with antibody enrichment for low-abundance complexes

  • Single-cell proteomics to analyze cell-to-cell variability

  • Spatial proteomics to map organelle-specific interactions

• High-throughput applications:

  • Microfluidic antibody arrays for rapid phenotyping

  • Automated imaging platforms for large-scale screens

  • Machine learning analysis of complex phenotypic data

  • Parallelized functional assays with antibody-based readouts

• In vivo applications:

  • Antibody-based imaging in model organisms

  • Implantable sensors with antibody components

  • Minimally invasive sampling techniques

  • Correlating ex vivo and in vivo measurements .

How might structural biology approaches complement antibody-based studies of grxD?

Structural biology approaches provide powerful complementary tools to antibody-based studies of grxD:

• Integrated structural analysis strategies:

  • Use antibodies to stabilize flexible regions for cryo-EM studies

  • Combine X-ray crystallography data with antibody epitope mapping

  • Validate structural predictions with antibody accessibility assays

  • Use conformation-specific antibodies to capture functional states

• Dynamic structural transitions:

  • Monitor iron-sulfur cluster transfer with time-resolved structural methods

  • Capture intermediate states with rapid mixing followed by crosslinking

  • Correlate structural changes with functional readouts

  • Develop computational models validated by antibody binding studies

• Protein-protein interaction characterization:

  • Determine binding interfaces with hydrogen-deuterium exchange mass spectrometry

  • Use antibody competition assays to map interaction surfaces

  • Apply integrative modeling combining multiple data types

  • Validate interaction models with targeted mutagenesis

• Structure-guided antibody development:

  • Design epitope-specific antibodies targeting functional regions

  • Generate conformation-selective antibodies for specific states

  • Develop antibodies distinguishing between apo- and holo-forms

  • Create tools to study species-specific structural differences

• Technical innovations:

  • Nanobody development for structural studies

  • In situ structural determination in cellular contexts

  • Single-particle tracking with antibody-based probes

  • Correlative microscopy linking structure to cellular localization .

What are the most significant unresolved questions in grxD research that antibody-based approaches could help address?

Several significant unresolved questions in grxD research could benefit from antibody-based approaches:

• Temporal dynamics of iron-sulfur cluster transfer:

  • How does grxD coordinate with other components of the iron-sulfur cluster assembly machinery?

  • What is the precise sequence of protein interactions during cluster transfer?

  • How are these processes regulated in response to cellular stresses?

  • Time-resolved antibody-based imaging could capture these dynamic processes

• Tissue and cell-type specific functions:

  • Do glutaredoxins have specialized functions in different cell types?

  • How do expression patterns correlate with metabolic requirements?

  • Are there tissue-specific interacting partners?

  • Immunohistochemistry and single-cell approaches could address these questions

• Post-translational modification landscape:

  • Beyond iron-sulfur cluster binding, what modifications regulate grxD?

  • How do these modifications change under stress conditions?

  • Do modifications create regulatory feedback loops?

  • Modification-specific antibodies would help map these regulatory networks

• Evolutionary conservation of mechanisms:

  • How conserved are the functions of grxD across diverse species?

  • What species-specific adaptations exist in various environments?

  • How have these proteins evolved different specializations?

  • Cross-species reactive antibodies could facilitate comparative studies

• Therapeutic targeting potential:

  • Can pathogen-specific epitopes be targeted for anti-infective development?

  • Would modulation of glutaredoxin function provide benefits in human diseases?

  • How can we selectively target disease-related dysregulation?

  • Antibody-based screening platforms could accelerate drug discovery .

What methodological advances are needed to overcome current limitations in grxD antibody research?

To overcome current limitations in grxD antibody research, several methodological advances are needed:

• Improved specificity and sensitivity:

  • Development of monoclonal antibodies with defined epitopes

  • Species-specific antibodies to distinguish closely related homologs

  • Conformation-selective antibodies that recognize specific functional states

  • Higher-affinity antibodies for detecting low-abundance complexes

• Technical innovations in imaging:

  • Antibody fragments compatible with super-resolution microscopy

  • Intracellular antibodies for live-cell imaging

  • Multiplexed detection systems for studying protein networks

  • Quantitative imaging standards for absolute quantification

• Functional antibody development:

  • Antibodies that selectively inhibit specific activities

  • Conformation-stabilizing antibodies for structural studies

  • Activity-modulating antibodies for mechanistic studies

  • Sensors based on antibody fragments for dynamic studies

• Systems biology integration:

  • High-throughput antibody-based assays for large-scale studies

  • Computational frameworks for integrating antibody-based data

  • Multi-omics approaches combining antibody detection with other techniques

  • Mathematical modeling incorporating antibody-derived parameters

• Reproducibility and standardization:

  • Validated antibody panels with defined specifications

  • Reference materials for quantitative comparisons

  • Standardized protocols optimized for different experimental systems

  • Improved reporting standards for antibody-based methods .

How might the study of grxD and related proteins impact broader understanding of iron metabolism in health and disease?

The study of grxD and related proteins using antibody-based approaches has potential for broad impacts on understanding iron metabolism in health and disease:

• Fundamental biological insights:

  • Elucidation of conserved mechanisms of iron-sulfur cluster assembly

  • Understanding of cellular adaptations to iron availability

  • Insights into evolutionary conservation of essential metabolic processes

  • Clarification of iron-dependent regulatory networks

• Disease mechanism understanding:

  • Connections between iron-sulfur cluster defects and neurodegenerative diseases

  • Mechanistic basis of certain anemias and mitochondrial disorders

  • Role of iron metabolism in cancer progression

  • Pathogen virulence mechanisms dependent on iron acquisition

• Diagnostic applications:

  • Biomarkers for iron-related disorders

  • Early detection of diseases affecting iron-sulfur cluster biogenesis

  • Monitoring disease progression and treatment response

  • Patient stratification for personalized therapeutic approaches

• Therapeutic development opportunities:

  • Novel targets for antimicrobial development

  • Approaches to modulate iron metabolism in cancer

  • Potential treatments for iron overload disorders

  • Therapeutic strategies for diseases with defective iron-sulfur cluster assembly

• Methodological advances applicable to other fields:

  • Techniques for studying transient protein complexes

  • Approaches for analyzing iron-dependent processes

  • Methods for detecting protein modifications

  • Systems for monitoring dynamic cellular responses .